articleTop 10% cited
Ritonavir: An Extraordinary Example of Conformational Polymorphism
Pharmaceutical Research · 2001 · Vol. 18(6) · pp. 859–866
John F. Bauer✉(Abbott (United Kingdom))Stephen G. Spanton(Abbott (United Kingdom))Rodger F. Henry(Abbott (United Kingdom))J. Quick(Abbott (United States))Walter Dziki(Abbott (United Kingdom))W.W. Porter(Abbott (United States))John B. Morris(Abbott (United Kingdom))
HIV/AIDS drug development and treatmentHepatitis C virus researchBiochemical and Molecular ResearchNucleationCrystallographyPolymorphism (computer science)SupersaturationHydrogen bondSolubilityChemistryCrystal structureCrystal (programming language)Infrared spectroscopy
MeSH terms
Calorimetry, Differential ScanningCrystallizationHydrogen BondingMolecular ConformationSolubilityHIV Protease InhibitorsCrystallography, X-RaySpectroscopy, Near-InfraredRitonavirNuclear Magnetic Resonance, Biomolecular
Citations
1,042
FWCI
5.62
field-weighted impact
References
17
Percentile
97%
vs. same field & year
Citations per year
Cited by
Pharmaceutical cocrystals: along the path to improved medicines
Chemical Communications · 2015 · 902 citations
Liquid–Liquid Phase Separation in Highly Supersaturated Aqueous Solutions of Poorly Water-Soluble Drugs: Implications for Solubility Enhancing Formulations
Crystal Growth & Design · 2013 · 350 citations
Diversity in Single- and Multiple-Component Crystals. The Search for and Prevalence of Polymorphs and Cocrystals
Crystal Growth & Design · 2007 · 533 citations
Trends in Solubility of Polymorphs
Journal of Pharmaceutical Sciences · 2005 · 497 citations
Pharmaceutical cocrystals and poorly soluble drugs
International Journal of Pharmaceutics · 2012 · 592 citations
References
Pharmaceutical Applications of Polymorphism
Journal of Pharmaceutical Sciences · 1969 · 849 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.